Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced
Maria Obrero1, David V Yu, David J Shapiro
1Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
Abstract:
The therapeutic efficacy of tamoxifen (TAM) in cancer therapy is thought to arise primarily from its ability to compete with estrogens for binding to the estrogen receptor (ER). We show that TAM and its active metabolite, 4-hydroxytamoxifen (OHT), can actively induce programmed cell death through distinct ER-dependent and ER-independent pathways. The ER-independent pathway is activated by 10-20 microm TAM and OHT and by 10-20 microm 17beta-estradiol and raloxifene, and occurs in ER-negative cells. The ER dependence of a second pathway, caused by submicromolar concentrations of TAM and OHT, was demonstrated by the ability of the ER ligands 17beta-estradiol, raloxifene, and ICI 182,780 to effectively block the cell death-inducing effects of TAM and OHT. Because the p38-specific inhibitor SB203580 blocks OHT.ER-induced cell death, stress kinase pathways are likely involved. ER-independent cell death triggers classic caspase-dependent apoptosis. However, although OHT.ER triggers some hallmarks of apoptosis, including Bax translocation and cytochrome c release, the absence of poly(ADP-ribose) polymerase cleavage or DNA laddering indicates that the death pathway involved is caspase-independent. The OHT.ER-dependent cell death pathway appears to diverge from classical apoptosis at the level of caspase 9 activation. The ability to promote ER-dependent programmed cell death represents a novel activity of TAM and OHT.
Insights
Tamoxifen (TAM) and its metabolite 4-hydroxytamoxifen (OHT) induce cancer cell death via estrogen receptor (ER)-dependent and ER-independent pathways. This novel finding reveals new therapeutic strategies for cancer treatment.
Area of Science:
- Cell Biology
- Pharmacology
- Cancer Research
Background:
- Tamoxifen (TAM) is a widely used cancer therapeutic agent, primarily functioning by competing with estrogens for estrogen receptor (ER) binding.
- The precise mechanisms underlying TAM's therapeutic efficacy, particularly its role in programmed cell death, are not fully elucidated.
Purpose of the Study:
- To investigate the distinct pathways through which TAM and its active metabolite, 4-hydroxytamoxifen (OHT), induce programmed cell death.
- To differentiate between ER-dependent and ER-independent mechanisms of cell death triggered by TAM and OHT.
Main Methods:
- Utilized various concentrations of TAM and OHT in both ER-positive and ER-negative cancer cell lines.
- Employed ER ligands (17beta-estradiol, raloxifene, ICI 182,780) and a p38 inhibitor (SB203580) to dissect signaling pathways.
- Assessed hallmarks of apoptosis, including Bax translocation, cytochrome c release, poly(ADP-ribose) polymerase cleavage, and DNA laddering.
Main Results:
- TAM and OHT induce programmed cell death through both ER-dependent and ER-independent pathways.
- The ER-independent pathway is activated at higher concentrations (10-20 micromolar) and occurs in ER-negative cells.
- The ER-dependent pathway, triggered by submicromolar concentrations, involves stress kinase pathways and diverges from classical caspase-dependent apoptosis.
Conclusions:
- Tamoxifen and 4-hydroxytamoxifen possess novel activities beyond ER antagonism, including the direct induction of programmed cell death.
- Understanding these distinct cell death pathways offers potential for developing more effective and targeted cancer therapies.
- The ER-dependent cell death pathway initiated by OHT appears to bypass key caspase activation steps, representing a unique mode of apoptosis induction.
More Related Videos
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
Apoptosis
The Intrinsic Apoptotic Pathway
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


